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Objective. Morphological and functional characterization of cocultured endothelial cells (EC) and myofibroblasts (MFB)
seeded on a matrix composed of a fibrin preparation mimicking the microenvironment of a vascular wall.
Methods.MFB and EC were isolated from human saphenous veins and expanded separately in vitro. MFB were seeded on a
composite matrix consisting of a fibrin preparation (with or without transforming growth factor-beta2) and a polyglactin-
mesh to form a 3-dimensional structure, which was consecutively reseeded with EC. Seeded matrices were incubated in a
bioreactor. Characterization was done including fluorescence staining, live-/dead-assay and immunohistochemistry.
Results. High density cocultures in hierarchical structure mimicking the formation of a vascular wall were obtained with
nearly complete coverage of the surface with EC. Distribution of preseeded MFB in a 519 ^ 27 mm thick layer (day 14) was
achieved. Cell viability was shown in fluorescence staining for at least 19 days. In deeper layers, no viable cells could be
detected within the fibrin preparation. EC covered the surface, had uniform morphology, and their preserved viability was
shown for at least 5 days. No EC-ingrowth was found into the fibrin preparation. Neoformation of the matrix proteins
laminin and collagen IV was observed.
Conclusion. A structured coculture of MFB and EC was obtained mimicking the formation of a vascular wall with
preserved viability utilizing a fibrin preparation. Nutrition problems seem to limit the maximal extent of MFB in the matrix.
Key Words: Tissue engineering; Fibrin; Polyglactin; Artificial vascular graft; Cell seeding; Endothelial cell; Myofibroblast;
In vitro.
Introduction
In contrast to large-caliber vascular grafts that are well
established clinically, the use of small-caliber prosthe-
sis (internal diameter #5 mm) is limited by biological
reactions to the graft material. Alloplastic materials
lead to foreign body reaction, activation of the
coagulation cascade, and platelet aggregation. Current
biodegradable grafts are damaged by inflammation,
setting the scene for thrombosis or long-term aneur-
ysm formation.1 Therefore, autologous blood vessels
remain the material of choice in coronary artery
surgery and below knee reconstruction.
Several attempts have been described to achieve
antithrombogenicity of small-caliber vascular grafts.2
Promising results were obtained by seeding the inner
surface of vascular grafts with autologous vascular
endothelium.3 Recent studies have shown the need for
more complex seeding procedures, especially if
biodegradable matrices are utilized. Excellent results
were achieved by coculturing endothelial cells (EC)
with smooth muscle cells.4 The arrangement of
myofibroblasts (MFB) and EC in a hierarchical
structure mimicking the vascular wall was found to
enhance attachment and long-term survival of EC.5
In a tissue engineering approach, we designed a
composite matrix utilizing a fibrin-preparation con-
nected with a woven mesh of the biodegradable
polymer polyglactin. The fibrin preparation was
chosen for its ability to promote invasion and
arrangement of smooth muscle cells and fibroblasts
in a 3-D-structure.6–8 It was combined with the
polymer to preserve a defined structure. EC were
subsequently seeded on a preformed layer of MFB to
mimic the structure of a natural vascular wall. Seeding
procedure was varied by addition of transforming
growth factor-b2 (TGF-b) to the fibrin preparation. The
aim of this study was the functional and morphologi-
cal characterization of MFB and EC seeded onto this
composite matrix.
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Material and Methods
Preparation of composite matrix
The composite matrix was composed by connecting a
fibrin-preparation with a woven polyglactin-mesh
(ETHICON, Norderstedt, Germany). The mesh was
minced into pieces of 8 £ 18 mm in size and assembled
with the fibrin-gel (Tissucol 1.0 Immuno, Baxter,
Munich, Germany).1
Isolation and expansion of human MFB and EC
Discarded saphenous vein segments of patients
undergoing aortocoronary bypass grafting were
stored in phosphate buffered saline (PBS, Sigma,
Germany) at 4 8C. The segments were filled with a
solution of collagenase A (Boehringer Mannheim,
Germany) 0.2% in PBS and incubated in an atmos-
phere with 5% CO2 at 37 8C. The vein was flushed with
50 ml M-199 medium (Biochrom, Germany) contain-
ing 10% fetal bovine serum (FBS, Gibco, MD, USA).
After centrifugation, the pellet was resuspended with
endothelial cell basal medium (EcBM, Bio-Whittaker,
Walkersville, MD, USA) and placed in gelatin-pre-
coated (1%) (Sigma) culture flasks (Corning Costar
Corporation, Cambridge, MA, USA). EC were incu-
bated (5% CO2, 37 8C), and the medium was replaced
every 2 days.
After enzymatic removal of EC the same segments
were prepared for isolation of MFB. The veins were
freed from adhering tissue, minced into small pieces,
that were placed in gelatin-precoated flasks and
incubated at 5% CO2 þ 37 8C. After attachment of the
fragments, medium was added. Cell types were
expanded separately. For seeding procedures, cells
were taken from the third or fourth passage, trypsi-
nised, centrifuged and washed.
Cell seeding
Cell-density was adjusted to accomplish a seeding-
density of 105 cells/cm2. Seeded matrices were placed
in polystyrene-wells (Nalge Nunc, NY, USA) and
incubated in an atmosphere with 5% CO2, 37 8C.
Medium was replaced every other day at 8 am.
Seeding experiments were modified by addition of
TGF-b2 to the fibrin preparation resulting in two
groups of experiments:
A: EC seeded on composite-matrices 14 days after
seeding with MFB ðn ¼ 15Þ:
B: seeding performed as described above plus
addition of TGF-b2 (10 ng/ml) to the fibrin
preparation ðn ¼ 9Þ:
Samples of the matrices were taken every day for
the first 14 days, after MFB were seeded, to perform
fluorescence live-/dead-assay and 5 days after EC
seeding for fluorescence staining and
immunohistochemistry.
Live/dead-fluorescence assay
Samples were stained using calcein and ethidiumho-
modimer-1 (Ethd-1, Molecular Probes, Eugene, OR,
USA). Calcein is actively converted to calcein AM in
viable cells, which appear green under fluorescence
microscope. Ethd-1 only accumulates in dead cells,
which appear red. This method allows to view cellular
morphology from the luminal surface and differentiate
between dead and viable cells by means of fluor-
escence microscopy.9
Immunohistochemistry
Immunohistological staining were performed for the
presence of CD31 (monoclonal mouse anti-human,
Clone JC/70A, DAKO, Hamburg, Germany) charac-
terizing EC, for a-actin (monoclonal mouse anti-
human, Clone 1A4, DAKO) for the characterization
of MFB, for laminin (monoclonal mouse anti-human,
Clone LAM-89, Sigma) and for collagen IV (mono-
clonal mouse anti-human, Clone CIV 22, DAKO)
within the extracellular matrix. Frozen cross sections
were stained using the avidin-peroxidase-technique
(APT). A goat anti-mouse served as secondary
antibody (DAKO). Streptavidine-peroxidase-conju-
gate was applied and the procedure was completed
by addition of diamino-benzidine (DAKO). Specimens
were viewed under light microscope. Corresponding
immunofluorescence stainings were made using a
fluorescein-isothiocyanat-(FITC)-(F(ab’)2) labeled goat
anti-mouse as secondary antibody (DAKO) in modi-
fied APT.
Statistical analysis
Continuous variables are expressed as median and
range. Differences between investigations were eval-
uated by means of non-parametric Wilcoxon test, if
appropriate. A p , 0:05 was considered significant.
SPSS 12.0 for Windows was used.
1Fibrin preparations were generously provided by Baxter, Munich,
Germany.
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Results
Group A: high density cocultures were obtained. EC
remained on the surface, whereas the preseeded MFB
invaded the matrix, spread and arranged to a
470 ^ 42 mm ðn ¼ 6Þ thick layer on day 4 (Figs. 1 and
2). Beyond this depth, only dead cells but no viable
cells could be detected. A line of dead cells was found
beyond the point of maximum ingrowth (Fig. 3). Even
after further days of cultivation no significant increase
in the thickness of the layer of MFB was found
(519 ^ 27 mm on day 14, n ¼ 6; p ¼ 0:138). Fluor-
escence analysis revealed persisting viability of MFB
for at least 19 days. A nearly complete coverage of the
surface with morphologically uniform EC was
obtained ðn ¼ 15Þ (Fig. 4).
By immunohistochemistry neoformation of both
matrix proteins laminin and collagen IV was found in
a small layer along the surface, which was reseeded
with EC (Fig. 5). Semiquantitative analysis revealed
the expression of laminin to a coherent layer, whereas
collagen IV was formed to an incoherent layer ðn ¼
10Þ:
Group B: arrangement and morphological
expression of MFB and EC was similar to the findings
in group A. Viability was demonstrated for 19 days
after seeding for MFB and 5 days for EC as well ðn ¼
9Þ: In immunohistochemical stainings, neoformation
of laminin and collagen IV were found. Semiquanti-
tative analysis revealed formation of both matrix
proteins to a coherent layer ðn ¼ 9Þ:
Matrices appeared to be more intact and stable in
group B at the end of the seeding experiments. In two
settings of group A, excessive degradation of the
matrix resulted in a nearly complete lysis of the fibrin
preparation.
Discussion
Long-term patency of small caliber vascular grafts is
closely related to their anatomic and functional
Fig. 2. The MFB migrated into the fibrin preparation. A depth of 500 mmwas in mean reached at day 4. No further migration
into the matrix was found.
Fig. 1. Cocultures of MFB and EC seeded on the composite matrix. (a) Shows a fluorescence staining with calcein and Ethd-1
96 h after MFB were seeded ( £ 200, group A). The viable MFB appear green in this assay and show no directed formation. A
nearly complete coverage of the surface was obtained, when matrices were reseeded with EC. (b) Shows immunohistological
staining for the presence of CD 31( £ 40, group A). MFB were positive for / -actin in immunohistological stainings (c) ( £ 40,
group B).
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properties.10 Other than large diameter aortic or iliac
prosthesis, at the present time small caliber grafts have
not been successfully applied in the clinical setting.
Therefore, ongoing research is required aiming at the
design of biocompatible arterial and venous substi-
tutes allowing long-term function after implantation.
It was our hypothesis that a biodegradable matrix
would be superior to non-absorbable matrices regard-
ing long-term function of small caliber vascular grafts
due to the absence of foreign body reaction and
platelet deposition often seen on non-absorbable
synthetic materials. In our opinion, a graft mimicking
the structure of a native vessel wall would be the
optimal solution to enhance EC attachment for
complete coverage of the surface and to obtain long-
term survival of EC.
In this series of experiments, we used a matrix of a
woven polyglactin-mesh for structural support com-
bined with a fibrin preparation, which are known to be
ideal matrices for cell support in cardiovascular8,11,12
and other fields of tissue engineering.13,14 Fibrin
preparations provide a number of advantages when
used as scaffold material. First, they give structural
support in a preformed shape until the seeded cells
have stabilized the matrix by neoformation of matrix
proteins. As a natural polypeptide, fibrin is degraded
by a cell-associated enzymatic system,15 which enables
MFB to invade the matrix and to arrange in a 3-D
extent inducing the tunica media of the vessel wall,
Fig. 3. The MFB spread in the fibrin preparation and formed a 500 mm thick layer. Beyond approximately 500 mm only dead
cells but no viable cells could be detected. A line of dead cells mark the line of maximal extent (fluorescence staining with
calcein and Ethd-1, £ 40, group A).
Fig. 4.A nearly complete coverage of the surface with EC was achieved. EC were morphological uniform. Their viability was
approved at day 5 after seeding in live/dead fluorescence staining ( £ 200).
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whereas EC remain on the surface. This arrangement
of the vascular cells is essential for the construction of
a hierarchical structure mimicking a vascular wall.
Fluorescence staining revealed maintained viability
of MFB to amaximum depth of 519 ^ 27 mmon day 14
after seeding. Beyond this depth, large numbers of
dead cells were found in fluorescence live-/dead
assay. Insufficient supply with oxygen and nutrients
seem to limit a further migration and spreading into
the fibrin gel. Recent studies report 3-D extent of
seeded fibroblasts in a fibrin preparation down to a
depth of 3 mm.4,11,12 However, cell viability was not
controlled in these studies, the thickness of the
obtained layer of MFB in our experiments, when the
cells were given onto the surface of the cured fibrin
preparation, was significant lower. With regard to the
mean wall thickness of human coronary arteries
ranging between 390 and 1300 mm with an outside
diameter between 3.9 and 5.7 mm,16 the maximum
thickness of a multilayer of viable MFB achieved in a
fibrin preparation, would allow for construction of
venous grafts and very small arteries only.
As shown in previous studies, biologically active
factors can be added to the fibrin preparation, and
their release allows for distinct physiological effects in
the seeded cells during lysis of the fibrin gel.9,17–19 We
found an increased expression of collagen IV and
morphologically more intact matrices at the end of
experiments after addition of TGF-b. However, these
findings have limited significance, because no quan-
titative assays and no functional studies were per-
formed in this study. Higher structural integrity and
durability is expected in cultures with higher amounts
of matrix proteins. Whether this morphological data
translate into higher grades of functional stability also,
is a matter of ongoing research in our laboratories.
Nevertheless, function of the seeded cells can be
modulated specifically. As such, formation of a 3-D
capillary network of EC in a fibrin gel has been
demonstrated following addition of fibroblast growth
factor-1 or vascular endothelial growth factor.19
Whether these technique can lead to a vascularized
matrix with sufficient supply for the ingrown cells
under either in vitro or in vivo condition however,
remains unknown.
Conclusion
A hierarchically organized vessel wall structure can be
achieved by seeding cocultures of EC and MFB on a
matrix of a fibrin preparation and polyglactin. A thin
layer (0.5 mm) of MFB was formed and their viability
was shown for at least 19 days. Subsequently seeded
EC remained on the surface and a nearly complete
coverage of the surface with uniform ECwas obtained.
Due to the limitation of the maximally achieved
thickness of a layer of viable cells, further investigation
is required to increase the thickness of viable vascular
structures prior to large animal studies and later
clinical use.
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